Nedaplatin in Treatment for Nasopharyngeal Carcinoma
Status:
Recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of induction chemotherapy with nedaplatin, docetaxel and
5-Fluorouracil followed by concurrent nedaplatin combined with radical radiotherapy in
locally advanced nasopharyngeal carcinoma.
Phase:
Phase 2
Details
Lead Sponsor:
Affiliated Cancer Hospital & Institute of Guangzhou Medical University